학술논문

Nonclinical development of next-generation site-specific HER2-targeting antibody–drug conjugate (ARX788) for breast cancer treatment
Document Type
Article
Source
In: Molecular Cancer Therapeutics. (Molecular Cancer Therapeutics, 1 September 2020, 19(9):1822-1832)
Subject
Language
English
ISSN
15388514
15357163